Voxzogo (vosoritide) Coverage
Customize your policy alerts
Sign up for all Colorado Rocky Mountain Health Plans policy alerts
Know when Colorado Rocky Mountain Health Plans releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs prior authorization and reauthorization for Voxzogo in pediatric patients with achondroplasia. Coverage applies to eligible patients under 18 years of age with open epiphyses, subject to clinical response requirements for continuation and restrictions against combination use with another CNP analog.
The policy added a requirement that Voxzogo not be used in combination with another C-type natriuretic peptide analog for both initial authorization and reauthorization.
The policy added a patient age requirement of less than 18 years to the reauthorization criteria.
The policy added an open-epiphyses requirement to reauthorization criteria.
The policy expanded the background indication to pediatric patients of all ages before the current coverage criteria specified an age limit of less than 18 years.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.